Pacific Biosciences of California PACB Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets?
- Pacific Biosciences of California (PACB) reported increase (decrease) in prepaid expense and other assets of $2.29M in Q1 2026.
- How has Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets increased by 166.8% year-over-year, from -$3.43M to $2.29M.
- What is the long-term trend for Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Pacific Biosciences of California's increase (decrease) in prepaid expense and other assets has grown at a -19.6% compound annual growth rate (CAGR), from $13.17M to -$8.51M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.